These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22155625)

  • 1. Inhibitory effects of C4a on chemoattractant and secretagogue functions of the other anaphylatoxins via Gi protein-adenylyl cyclase inhibition pathway in mast cells.
    Xie P; Nishiura H; Semba U; Chen J; Zhao R; Kuniyasu A; Yamamoto T
    Int Immunopharmacol; 2012 Jan; 12(1):158-68. PubMed ID: 22155625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
    Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
    J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of high- and low-affinity receptors for C3a on the human mast cell line, HMC-1.
    Legler DF; Loetscher M; Jones SA; Dahinden CA; Arock M; Moser B
    Eur J Immunol; 1996 Apr; 26(4):753-8. PubMed ID: 8625964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
    Tsu RC; Allen RA; Wong YH
    Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the ribosomal protein S19 C-terminus in Gi protein-dependent alternative activation of p38 MAP kinase via the C5a receptor in HMC-1 cells.
    Nishiura H; Tokita K; Li Y; Harada K; Woodruff TM; Taylor SM; Nsiama TK; Nishino N; Yamamoto T
    Apoptosis; 2010 Aug; 15(8):966-81. PubMed ID: 20473571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells are not required for anaphylatoxin-induced ileal smooth muscle contraction.
    Stimler-Gerard NP; Galli SJ
    J Immunol; 1987 Mar; 138(6):1908-13. PubMed ID: 2434565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins.
    Shum JK; Allen RA; Wong YH
    Biochem Biophys Res Commun; 1995 Mar; 208(1):223-9. PubMed ID: 7887933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3a and C5a stimulate chemotaxis of human mast cells.
    Hartmann K; Henz BM; Krüger-Krasagakes S; Köhl J; Burger R; Guhl S; Haase I; Lippert U; Zuberbier T
    Blood; 1997 Apr; 89(8):2863-70. PubMed ID: 9108406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbachol-induced decrease in thyroid cell adenylyl cyclase activity is independent of calcium and phosphodiesterase activation.
    Pasquali D; Rani CS; Deery WJ
    Mol Pharmacol; 1992 Jan; 41(1):163-7. PubMed ID: 1310140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
    Li Y; Hashim S; Anand-Srivastava MB
    Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.
    Hugli TE
    Crit Rev Immunol; 1981 Feb; 1(4):321-66. PubMed ID: 7037298
    [No Abstract]   [Full Text] [Related]  

  • 15. F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins.
    Basta M; Van Goor F; Luccioli S; Billings EM; Vortmeyer AO; Baranyi L; Szebeni J; Alving CR; Carroll MC; Berkower I; Stojilkovic SS; Metcalfe DD
    Nat Med; 2003 Apr; 9(4):431-8. PubMed ID: 12612546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement peptides C3a- and C5a-induced mediator release from dissociated human skin mast cells.
    el-Lati SG; Dahinden CA; Church MK
    J Invest Dermatol; 1994 May; 102(5):803-6. PubMed ID: 7513741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide modulates Gi-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells.
    Bassil M; Anand-Srivastava MB
    Free Radic Biol Med; 2006 Oct; 41(7):1162-73. PubMed ID: 16962941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine stimulates 45Ca2+ uptake through cAMP, PLC/PKC, and MAPKs in renal proximal tubule cells.
    Han JY; Heo JS; Lee YJ; Lee JH; Taub M; Han HJ
    J Cell Physiol; 2007 May; 211(2):486-94. PubMed ID: 17167784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle.
    Hashim S; Li Y; Nagakura A; Takeo S; Anand-Srivastava MB
    Cardiovasc Res; 2004 Sep; 63(4):709-18. PubMed ID: 15306227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic regulation of mast cell activation and secretion by adenylate cyclase and cyclic AMP-dependent protein kinases.
    Winslow CM; Austen KF
    Fed Proc; 1982 Jan; 41(1):22-9. PubMed ID: 6173264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.